FindTrial
Sign In

Prescription trends in end of life Cancer Patients: An Observational Study

Prescription Patterns in Terminally Ill Cancer Patients: A Prospective Observational Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/09/057783
Enrollment
200
Registered
2023-09-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Dr V Divya Sai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Terminally Ill Cancer patients

Exclusion criteria

Exclusion criteria: Less than 12 years of age, those who have not consented for End of life care Unrelated sudden deaths which are not due to cancer

Design outcomes

Primary

MeasureTime frame
To evaluate the prescription changes in terminally ill cancer patients at the time of their admission and after palliative interventionTimepoint: September 2023- September 2024—

Secondary

MeasureTime frame
To Assess the symptom burden in terminally ill cancer patientsTimepoint: September 2023- September 2024—

Countries

India

Contacts

Public ContactDr Praneeth Suvvari

Indo American Cancer Hospital & Research Institute

praneethsuv@gmail.com9814686999

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026